Board Member
enGene Therapeutics Inc. (ENGN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Ron Cooper is recorded as CEO and Board Member at enGene Therapeutics Inc. (ENGN). enGene Therapeutics Inc. reported in an 8-K filed July 24, 2024 that Ron Cooper was appointed member of the Board of Directors, effective July 22, 2024. enGene Therapeutics Inc. reported in an 8-K filed July 24, 2024 that Ron Cooper was appointed Chief Executive Officer, effective July 22, 2024. Ron Cooper has spoken on 2 investor events across 1 company, most recently for enGene Therapeutics Inc. on September 15, 2026.
“today announced that Ron Cooper has joined the Company as Chief Executive Officer and member of the Board of Directors, effective July 22, 2024.”
“today announced that Ron Cooper has joined the Company as Chief Executive Officer and member of the Board of Directors, effective July 22, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2024-07-22–present
2024-07-22–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2024-07-22–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
